Plunkett Research Online: Tissue Therapies

TISSUE THERAPIES (TSSHF:GREY) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Factor Therapeutics Ltd is a biotechnology company. It is engaged in development and commercialisation of wound care therapeutics. Its product VF-001 is developed to treat venous leg ulcers......



Tissue Therapies
Ticker: TSSHF
Exchange: GREY
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 61 733343900
Fax: 61 733343999
Address: BTP Hub
Suite 7, 1 Westlink Court
Darra
Brisbane, QLD 4000 Australia

Types Of Business
Industry Ranks

Industry NAICS code:


Ranks not available
ContactsDescription

Factor Therapeutics Ltd is a biotechnology company. It is engaged in development and commercialisation of wound care therapeutics. Its product VF-001 is developed to treat venous leg ulcers......See More See More

Auditor:
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201620152014201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: